Virulence factors of candida albicans;Czynniki chorobotwórczości candida albicans

Mikologia Lekarska

Volumn 17, Issue 2, 2010, Pages 134-137

  Krutkiewicz, Alicja ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Candida albicans; Infection; Pathogenesis

Indexed keywords

ASPARTIC PROTEINASE; PHOSPHOLIPASE;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; ENZYME ACTIVITY; FUNGAL VIRULENCE; IMMUNE ADHERENCE; IMMUNITY; MORPHOGENESIS; NONHUMAN; PATHOGENESIS;

CANDIDA; CANDIDA ALBICANS; MAMMALIA;

EID: 78649727363     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rex J.H.: Epidemiology of serious Candida infections. [w:] Serious Candida infections: risk factors, treatment and prevention. Pfizer INC, Houston, 1995, 1-2.
2. Eggimann A., Garbino J., Pittet D.: Epidemiology of Candida species infections in critically ill nonimmunosupressed patients. Inf. Dis., 2003, 3, 685-701.
3. Batura-Gabryel H.: Wybrane czynniki warunkujace wystepowanie grzybów z rodzaju Candida u chorych z przewleklymi chorobami ukladu oddechowego bez neutropenii. [Rozprawa habilitacyjna]. Poznan, 2001.
4. Gale C.A., Bendei C.M., MeCIelIan M., Hauser M., Becker J.M., Berman J.: Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science, 1998, 27, 1355-1358.
5. Nikawa H., Egusa H., Makihira S., Okamota T., Kurihara H., Shiba H.: An in vitro evaluation of the adhesion of Candida species to oral and lung tissue cells. Mycoses, 2006, 49, 14-17.
6. Calderone R.A., Fonzi W.A.: Virulence factors of Candida albicans. Trends Microbiol., 2001, 9, 327-335.
7. Calderone R., Suzuki S., Cannon R., Cho T., Boyd D., Calera J., Chibana H., Herman D., Holmes A., Jeng H.W., Kaminishi H., Matsumoto T., Mikami T. O., Sullivan J.M., Sudoh M., Suzuki M., Nakashima Y., Tanaka T., Tompkins G.R., Watanabe T.: Candida albicans: adherence, signaling and virulence. Med. Mycol., 2000, 38, Suppl. 1, 125-137.
8. Frieman M.B., McCaffery J.M., Cormack B.P.: Modular domain structure n the Candida glabrata adhesin Epa1p, a b1,6 glucancross- linked cell wall protein. Mol. Microbiol., 2002, 46, 479-492.
9. Hoyer L.L.T: he ALS gene family of Candida albicans. Trends Microbiol., 2001, 9, 176-180.
10. Kapteyn J.C., Hoyer L.L., Hecht J.E., Müller W.H., Andel A., Verkleij A.J., Makarow M., Van Den Ende H., Klis F.M.: The cell wall architecture of Candida albicans wild-type cells and cell wall- defective mutants. Mol. Microbiol., 2000, 35, 601-611.
11. Gale Ch., Finkel D., Tao N., Meinke M., McClellan M., Olson J., Kendrick K., Hostetter M.: Cloning and expression of a gene encoding an integrin-like protein in Candida albicans. Proc. Natl. Acad. Sci. USA, 1996, 93, 357-361.
12. Karkowska-Kuleta, J., Rapala-Kozik, M., Kozik A.: Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Bioch. Pol., 2009, 56, 211-224.
13. Shepherd M.G.: Cell envelope of Candida albicans. Crit. Rev. Microbiol., 1987, 15, 7-25.
14. Mnichowska M., Giedrys-Kalemba, S.: Funkcjonalne, strukturalne i molekularne spojrzenie na adhezje Candida spp. Mikol. Lek., 2004, 11, 309-316.
15. Yang Y.L.: Virulence factors of Candida species. J Microbiol. Immunol. Infect., 2003, 36, 223-228.
16. Davis D. Wilson R.B., Mitchell A.P.: RIM101-dependent and -independent pathways govern pH responses in Candida albicans. Mol. Cel. Biol., 2000, 20, 971-975.
17. Dongmei Li D., Williams D., Lowman D., Monteiro M.A., Tan X., Kruppa M., Fonzi W., Roman E., Pla J., Calderone R.: The Candida albicans histidine kinase Chk1p: signaling and cell wall mannan. Fungal Gen. Biol., 2009, 46, 731-741.
18. Roman E., Cottier F., Ernst J.F., Pla J.: Msb2 signaling mucin controls activation of Cek1 mitogenactivated protein kinase in Candida albicans. Eukaryotic Cell, 2009, 8, 1235-1249.
19. Naglik J., Challacombe S., Hube B.: Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev., 2003, 400-428.
20. Batura-Gabryel H., Mlynarczyk W.: Aktywnosc proteolityczna i lipolityczna grzybów z rodzaju Candida wyizolowanych od chorych na przewlekle choroby ukladu oddechowego. Mikol. Lek., 2000, 7, 139-143.
21. Borstt A., Fluit A.C.: High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J. Med. Microbiol., 2003, 52, 971-974.
22. Schaller M., Barelli C., Kortong H.C., Hube B.: Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses, 2005, 48, 365-378.
23. Mathews R.C.: Pathogenicity determinants of Candida albicans: potential targets for immunotheraphy? Microbiology, 1994, 140, 1505-1511.
24. Ghannoum M.A.: Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev., 2000, 13, 122-143.
25. Srikantha T., Soll D. R.: A white-specific gene in the white-opaque switching system of Candida albicans. Gene, 1993, 131, 53-60.
26. Yang Y.L.: Virulence factors of Candida species. J. Microbiol. Immunol. Infect. 2003, 36, 223-228.